Page 3 - அப்போட் ஆய்வகங்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அப்போட் ஆய்வகங்கள் லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அப்போட் ஆய்வகங்கள் லிமிடெட் Today - Breaking & Trending Today

Global Rapid Test Kit Markets 2021-2026 by Type, Product, Technology, Duration, Application, End Users, & Region

Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Rapid Test Kit Market was valued at USD 23.44 Billion in 2020 and is expected to grow at a formidable rate of 8.14% during the forecast period.
The Global Rapid Test Kit Market is driven by the growing prevalence of various infectious diseases. Additionally, benefits associated with rapid test kits such as low cost, accuracy, early disease diagnosis, quick results, stability at high temperature, among others are further expected to propel the market growth through 2026.
Moreover, sudden outbreak and spread of pandemic COVID-19 has drastically increased the demand for rapid test kits, thereby fueling the market growth during the forecast period. Many major biotechnology and pharmaceutical companies have developed their own rapid test kits, and many are still investing, researching and working on the development of better and advanced rapid test kits. This in turn is expected to ....

United States , United Kingdom , South Africa , Saudi Arabia , South Korea , Laura Wood , Danaher Corporation Cepheid Inc , Perkinelmer Inc , Cellex Inc , Abbott Laboratories Ltd , Mesa Biotech Inc , Technology Lateral Flow Assays , Orasure Technologies Inc , Custom Research , Office Hours Call , Research Methodology , E St Office Hours Call , Bio Rad Laboratories Inc , Akers Biosciences Inc , Biofire Diagnostics Inc , Thermo Fisher Scientific Inc , Luminex Corporation , Rapid Test Kit Market , Rapid Antigen Test , Rapid Antibody Test , Product Type ,

Lupin Q3 net profit beats expectations, but Street awaits more triggers

Lupin Q3 net profit beats expectations, but Street awaits more triggers
The move impacts multinational drugmakers, like Abbott Laboratories Ltd and GlaxoSmithKline Plc, and a number of local firms, including Lupin Ltd, Cadila Healthcare Ltd and Ipca Ltd, all of whom sell drugs added to the list. Photo: Bloomberg
1 min read
Share Via
Read Full Story
Lupin s December quarter performance was led by a recovery in US sales growth, though domestic sales also revived after facing covid-19 led disruptions.
US, which remains the largest market and drives overall earnings, grew well during the quarter. North America sales, contributing 37% to overall revenues, grew 4.8% year-on-year. US sales, at $188 million, were slightly higher than $186 million seen in the previous year and $180 million in the previous quarter. The quarter saw three product launches in the US market, taking the number of products in the US generics market to 169. ....

United States , Asia Pacific , Glaxosmithkline Plc , Abbott Laboratories Ltd , Analysts At Motilal Oswal Financial Services , Quess Corp , Cadila Healthcare Ltd , Lupin Ltd , Ipca Ltd , Nasdaq Composite Index , Motilal Oswal Financial Services Limited , Join Mint , ஒன்றுபட்டது மாநிலங்களில் , ஆசியா பெஸிஃபிக் , கிளாக்சோஸ்மித்க்லைன் ப்ல் , அப்போட் ஆய்வகங்கள் லிமிடெட் , ஆய்வாளர்கள் இல் மோட்டிலால் ஒசுவள் நிதி சேவைகள் , க்வெஸ் கார்ப் , காடிலா சுகாதாரம் லிமிடெட் , லூபின் லிமிடெட் , இப்க லிமிடெட் , நாஸ்டாக் கலப்பு குறியீட்டு , மோட்டிலால் ஒசுவள் நிதி சேவைகள் வரையறுக்கப்பட்டவை , சேர புதினா ,

Diabetic Retinopathy Market Global Industry Analysis and Growth By 2020 – Size, Share, Trends, Oppor

Search jobs
14-Jan-2021
Diabetic Retinopathy Market Global Industry Analysis and Growth By 2020 – Size, Share, Trends, Opportunities, Top 5 Key Players and Regional Forecast Up To 2027
Diabetic retinopathy is one of the complications of diabetes, in which blood vessels in the retina gets damaged due to high blood glucose level. Retina is the light sensitive inner lining at the back of the eye. Diabetic retinopathy mostly affects both the eyes. As disease condition progresses, diabetic retinopathy symptoms including fluctuating vision, blurred vision, impaired color vision or sometimes dark and empty areas in vision leads to vision loss. The line of treatment for diabetic retinopathy depending on the disease condition of the patient, may require laser surgery, intraocular injections, and anti (VEFG) vascular endothelial growth factor therapy. ....

United States , United Kingdom , Nordrhein Westfalen , Asia Pacific , International Diabetic Federation , International Agency For The Prevention Of Blindness , Actavis Plc , National Health Interview , Boehringer Ingelheim , Abbott Laboratories Ltd , Therapeutics Inc , Pfizer Inc , Regeneron Pharmaceuticals , Roche Ltd , Union Health Ministry , Research Methodology , Drug Administration , Diabetic Retinopathy , National Diabetes , University Of Bonn , Lupin Ltd , Sample Copy , Business Report , International Agency , Regeneron Pharmaceutical , Many Research ,